Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol

被引：11
|
作者：
Yasui-Furukori, N
Kondo, T
Suzuki, A
Mihara, K
Tokinaga, N
Inoue, Y
Otani, K
Kaneko, S
机构：
[1] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan
[2] Welfide Corp, Pharmaceut Res Div, Fukuoka, Japan
[3] Yamagata Univ, Sch Med, Dept Neuropsychiat, Yamagata 99023, Japan
来源：
SCHIZOPHRENIA RESEARCH | 2001年 / 52卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(00)00178-X
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：139 / 142
页数：4
相关论文
共 50 条
  • [21] CYP2D6 inhibition in patients treated with sertraline
    Sproule, BA
    Otton, SV
    Cheung, SW
    Zhong, XH
    Romach, MK
    Sellers, EM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (02) : 102 - 106
  • [22] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients
    Ueda, M
    Hirokane, G
    Morita, S
    Okawa, M
    Shimoda, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 181 - 181
  • [23] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients
    Ueda, M
    Hirokane, G
    Morita, S
    Yokono, A
    Okawa, M
    Shimoda, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S223 - S223
  • [24] CYP2D6 genotype and tamoxifen response
    James M Rae
    Matthew P Goetz
    Daniel F Hayes
    James N Ingle
    Lang Li
    Anna Maria Storniolo
    Vered Stearns
    David A Flockhart
    Breast Cancer Research, 7
  • [25] Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6
    Ohnuma, T
    Shibata, N
    Matsubara, Y
    Arai, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) : 315 - 320
  • [26] CYP2D6 Genotype and Adjuvant Tamoxifen
    Berry, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 138 - 140
  • [27] Metabolism of antipsychotics and CYP2D6 genotype
    Schmider, J
    Walter, S
    Sachse, C
    Bauer, S
    Müller-Oerlinghausen, B
    Roots, I
    Brockmöller, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R459 - R459
  • [28] CYP2D6 genotype and tardive dyskinesia
    Sajjad, SHA
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 : 580 - 580
  • [29] CYP2D6 genotype and tamoxifen response
    Rae, JM
    Goetz, MP
    Hayes, DF
    Ingle, JN
    Li, L
    Storniolo, AM
    Stearns, V
    Flockhart, DA
    BREAST CANCER RESEARCH, 2005, 7 (05)
  • [30] CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYP2D6
    MCLEOD, HL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) : 463 - 463
12345